Veeva Systems is expanding its presence in the randomization and trial supply management market, which management identified as a key long-term growth driver for its research and development business. During the fourth quarter of fiscal 2026 earnings call, executives highlighted a major win involving a top-20 pharmaceutical company that standardized on Veeva’s RTSM platform.
This achievement underscores growing customer confidence in the company’s broader clinical ecosystem strategy.
Executives characterized the RTSM product area as being as significant as the electronic data capture (EDC) segment. The platform plays a mission-critical role in managing global drug supply logistics, patient randomization, and trial execution. Veeva Systems noted that large pharmaceutical customers are increasingly seeking enterprise-scale RTSM solutions rather than relying on smaller, standalone vendors, creating a favorable competitive environment for the company.
The company emphasized that the RTSM opportunity extends beyond a single product cycle. It supports a broader study-by-study clinical software expansion strategy. Products such as RTSM, EDC, and electronic clinical outcomes assessment (eCOA) are sold on a study-by-study basis, collectively representing a potentially multibillion-dollar opportunity.
Veeva Systems is also increasing its focus on contract research organization (CRO) partnerships, allowing these organizations to offer its technologies directly within clinical trials.
This strategy aims to significantly expand Veeva Systems' reach across emerging biotech and midsized pharma customers while strengthening adoption of its broader Development Cloud platform. With strong execution across clinical applications and increasing enterprise standardization wins, RTSM appears well-positioned to become another meaningful growth pillar for the company in the coming years.
In related industry news, Salesforce continues to expand its healthcare and enterprise AI capabilities through its Agentforce platform. The company recently partnered with HealthEx, Verily, and Viz.ai to introduce AI-powered healthcare agents designed to streamline administrative and clinical workflows. Salesforce has also strengthened collaborations with OpenAI and Anthropic to enhance Agentforce 360, enabling enterprises to integrate advanced generative AI capabilities directly into Salesforce environments.
